Enzo Biochem CEO Elazar Rabbani's 2009 pay jumps 21% to $1.3M
Enzo Biochem reports 2009 executive compensation
By ExecPay News
Published: December 23, 2009
Enzo Biochem reported fiscal year 2009 executive compensation information on December 23, 2009.
In 2009, six executives at Enzo Biochem received on average a compensation package of $597K, a 11% decrease compared to previous year.
Average pay of disclosed executives at Enzo Biochem
Elazar Rabbani, Chief Executive Officer, received $1.3M in total, which increased by 21% compared to 2008. 41% of Rabbani's compensation, or $535K, was in salary. Rabbani also received $465K in bonus, $190K in stock awards, as well as $115K in other compensation.
Barry W. Weiner, Chief Financial Officer, received a compensation package of $1.1M, which increased by 25% compared to previous year. 44% of the compensation package, or $474K, was in salary.
Shahram K. Rabbani, Secretary, earned $390K in 2009, a 50% decrease compared to previous year.
Carl W. Balezentis, President, Enzo Life Sciences, received $349K in 2009, which increases by 10% compared to 2008.
Andrew R. Crescenzo, Senior Vice President of Finance, earned $344K in 2009, a 15% increase compared to previous year.
Kevin Krenitsky, Former President of Enzo Clinical Labs, received $112K in 2009.
Enzo Biochem's fiscal year ends on July 31.
Related executives
Elazar Rabbani
Enzo Biochem
Chief Executive Officer
Barry Weiner
Enzo Biochem
President and Treasurer
Andrew Crescenzo
Enzo Biochem
Senior Vice President of Finance
Kevin Krenitsky
Enzo Biochem
Former President of Enzo Clinical Labs
Carl Balezentis
Enzo Biochem
President, Enzo Life Sciences
Shahram Rabbani
Enzo Biochem
Secretary
You may also like
Source: SEC filing on December 23, 2009.